Allen Seylani, Yohannes Haile, Assal Sadighian. "Risk of autoimmune hepatitis, non-infectious gastroenteritis, and colitis among patients with metastatic clear cell renal cell carcinoma (ccRCC) treated with pembrolizumab/axitinib vs nivolumab/ipilimumab.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e16530